Marcus Sucksdorff

Sex Comparison of White-Blood-Cell Responses to Acute Vigorous-Intensity Aerobic Exercise (2025)

International Journal of Sports Physiology and Performance

Koivula, Tiia; Neuvonen, Joona; Sucksdorff, Marcus; Kapanen, Jukka; Heinonen, Olli J.; Rissanen, Eero; Heinonen, Ilkka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis (2025)

Journal of Neuroinflammation

Nylund, Marjo; Lehto, Jussi; Matilainen, Markus; Rajander, Johan; Wahlroos, Saara; Sucksdorff, Marcus; Kuhlmann, Tanja; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Predictors of risk of secondary progression in multiple sclerosis (2025)

Therapeutic Advances in Neurological Disorders

Laaksonen, Sini; Sucksdorff, Marcus; Vuorimaa, Anna; Kuhle, Jens; Nylund, Marjo; Rajander, Johan; Wahlroos, Saara; Matilainen, Markus; Saraste, Maija; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)

BMJ neurology open

Radford-Smith, Daniel E.; Yates, Abi G.; Kacerova, Tereza; Nylund, Marjo; Sucksdorff, Marcus; Matilainen, Markus; Willemse, Eline; Oechtering, Johanna; Maceski, Aleksandra Maleska; Leppert, David; Kuhle, Jens; Probert, Fay; Anthony, Daniel C.; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study (2024)

EJNMMI Research

Lehto, Jussi; Aarnio, Richard; Tuisku, Jouni; Sucksdorff, Marcus; Koivumäki, Esa Mikko; Nylund, Marjo; Helin, Semi; Rajander, Johan; Danon, Jonathan; Gilchrist, Jayson; Kassiou, Michael; Oikonen, Vesa; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Smouldering Inflammation in Multiple Sclerosis – A PET Imaging Study on Prediction of Disease Progression and Effects of Treatment (2024)

Sucksdorff Marcus

(G5 Artikkeliväitöskirja)

Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy (2024)

European Journal of Clinical Microbiology and Infectious Diseases

Feuth Eeva, Nieminen Valtteri, Palomäki Antti, Ranti Juha, Sucksdorff Marcus, Finnilä Taru, Oksi Jarmo, Vuorinen Tytti, Feuth Thijs

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)

European Journal of Neurology

Lehto Jussi, Nylund Marjo, Matilainen Markus, Sucksdorff Marcus, Vuorimaa Anna, Rajander Johan, Wahlroos Saara, Hariri Parisa, Laura Airas

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)

Journal of Neurology

Lehto Jussi, Sucksdorff Marcus, Nylund Marjo, Raitanen Roope, Matilainen Markus, Airas Laura

(B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä )

Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)

Multiple Sclerosis and Related Disorders

Laaksonen Satu, Saraste Maija, Sucksdorff Marcus, Nylund Marjo, Vuorimaa Anna, Matilainen Markus, Heikkinen Jaakko, Airas Laura

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Marcus

Sucksdorff

Contact

Publications

Sort by:

Sex Comparison of White-Blood-Cell Responses to Acute Vigorous-Intensity Aerobic Exercise (2025)

Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis (2025)

Predictors of risk of secondary progression in multiple sclerosis (2025)

Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)

P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study (2024)

Smouldering Inflammation in Multiple Sclerosis – A PET Imaging Study on Prediction of Disease Progression and Effects of Treatment (2024)

Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy (2024)

Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)

PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)

Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)